問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
蕭惠樺
下載
2018-06-26 - 2030-12-31
Condition/Disease
Chronic Lymphocytic Leukemia
Test Drug
Venetoclax
Participate Sites8Sites
Recruiting7Sites
2020-01-11 - 2027-12-31
After Allogeneic Stem Cell Transplantation in Subjects With Acute Myeloid Leukemia (AML)
VenetoclaxVenetoclax
Participate Sites6Sites
Recruiting6Sites
2019-10-23 - 2025-12-31
Myelofibrosis (MF)
Navitoclax
Participate Sites2Sites
Recruiting2Sites
2017-07-18 - 2026-06-30
2022-01-14 - 2026-07-31
xxxxxx
Participate Sites5Sites
Not yet recruiting1Sites
Recruiting4Sites
2024-10-31 - 2029-02-28
Recruiting8Sites
2024-05-01 - 2028-12-22
Participate Sites3Sites
Recruiting3Sites
2021-12-10 - 2028-06-30
Terminated1Sites
2021-10-01 - 2027-12-31
2018-06-01 - 2026-12-31
Participate Sites4Sites
全部
